Carregant...

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Format: Artigo
Idioma:Inglês
Publicat: BMC 2017-12-01
Col·lecció:Alzheimer’s Research & Therapy
Matèries:
Accés en línia:http://link.springer.com/article/10.1186/s13195-017-0321-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!